	Bénéfice Avant Impôts		Date
AbbVie	USD 4.38B	1.92B	2025-09
Acadia Pharmaceuticals	USD 44.6M	4.38M	2025-09
Akebia Therapeutics	USD 6.11M	28.92M	2025-03
ALKERMES	USD 100.74M	4.1M	2025-09
Alnylam Pharmaceuticals	USD 238.97M	274.33M	2025-09
Amarin	USD -8.12M	5.34M	2025-09
Amgen	USD 3.92B	2.35B	2025-09
Baxter International	USD 121M	12M	2025-09
Biogen	USD 557.3M	186.7M	2025-09
BioMarin Pharmaceutical	USD -26.32M	324.19M	2025-09
Bristol-Myers Squibb	USD 3.11B	1.34B	2025-09
Coherus Biosciences	USD -47.4M	14.9M	2025-03
Eli Lilly	USD 7.23B	456M	2025-09
Fujifilm	JPY 100.28B	10.32B	2025-12
Gilead Sciences	USD 3.64B	1.21B	2025-09
Ironwood Pharmaceuticals	USD 68.02M	30.2M	2025-09
Merck	USD 6.74B	22M	2025-09
Myriad Genetics	USD 6.2M	2.1M	2024-12
Pacira	USD -1.93M	10.63M	2025-06
Perrigo	USD 22.4M	19.2M	2025-09
Pfizer	USD 3.33B	290M	2025-09
PTC Therapeutics	USD -23.07M	47.98M	2025-09
Regeneron Pharmaceuticals	USD 1.76B	244.6M	2025-09
Sarepta Therapeutics	USD -194.05M	347.69M	2025-09
Teva Pharmaceutical Industries	USD 91M	555M	2025-12
Vertex Pharmaceuticals	USD 1.3B	15.8M	2025-09
Xencor	USD -6.03M	25.05M	2025-09
Zoetis	USD 887M	15M	2025-09

Coherus Biosciences Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.